Ask AI

Optimizing DLBCL Treatment: An Expert Roundtable on the Role of New and Emerging Targeted Therapies

Learn more about the role of new and emerging targeted therapies in the management of patients with diffuse large B-cell lymphoma (DLBCL) through an on-demand webcast, podcast, downloadable slides, and expert-authored commentary.

Share

Program Content

Activities

New and Emerging Therapies in DLBCL
Optimizing DLBCL Treatment: An Expert Roundtable on the Role of New and Emerging Targeted Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2026

Activities

New and Emerging Targeted Therapies in DLBCL
Optimizing DLBCL Treatment: An Expert Roundtable on the Role of New and Emerging Targeted Therapies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2026

Expires: December 29, 2026

Activities

Targeted Therapies in DLBCL
Evolving Targeted Therapies for Relapsed/Refractory DLBCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 06, 2026

Terapias dirigidas en el LDCBG
Evolución de las terapias dirigidas en el linfoma difuso de células B grandes (LDCBG) recidivante/refractario
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2026

Gezielte Therapien bei DLBCL
Neue zielgerichtete Therapien für das rezidivierte/refraktäre diffus großzellige B-Zelllymphom (DLBCL)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2026

Thérapies ciblées dans le lymphome diffus à grandes cellules B (LDGCB)
Évolution des thérapies ciblées pour le lymphome diffus à grandes cellules B récidivant/réfractaire (LDGCB)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2026

Terapie mirate nel DLBCL
Evoluzione delle terapie mirate per il linfoma diffuso a grandi cellule B recidivante/refrattario
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2026

Activities

Emerging Therapies in DLBCL
New and Emerging Targeted Therapies for Patients With DLBCL
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from AstraZeneca.

AstraZeneca